TABLE 1.
Patient characteristics.
| Variable | Non‐ASCT (N = 82) | ASCT (N = 37) | p |
|---|---|---|---|
| Age at diagnosis, years (range) | 51.5 (19–60) | 48 (19–60) | 0.097 |
| Sex, female, N (%) | 38 (46.3) | 12 (32.4) | 0.222 |
| GCB type, N (%) | 28 (34.1) | 11 (29.7) | 0.792 |
| IPI score high, N (%) | 21 (25.6) | 14 (37.8) | 0.255 |
| Interim PET Deauville score 3 or 4 | 24 (29.3) | 13 (35.1) | 0.67 |
| End‐of‐treatment PET Deauville score | 0.543 | ||
| 1 | 53 (64.6) | 20 (54.1) | |
| 2 | 21 (25.6) | 12 (32.4) | |
| 3 | 8 (9.8) | 5 (13.5) | |
| SUVmax (> 18), N (%) | 23 (28) | 15 (40.5) | 0.254 |
| Bulky disease (≥ 7.5 cm), N (%) | 17 (20.7) | 12 (32.4) | 0.252 |
| Spleen involvement, N (%) | 26 (31.7) | 11 (29.7) | 0.999 |
| Bone marrow involvement, N (%) | 25 (30.5) | 10 (27.0) | 0.868 |
| Nasosinusal involvement, N (%) | 19 (23.2) | 12 (32.4) | 0.401 |
| Mediastinum involvement, N (%) | 24 (29.3) | 12 (32.4) | 0.895 |
| Lung or pleura involvement, N (%) | 15 (18.3) | 6 (16.2) | 0.988 |
| Liver involvement, N (%) | 8 (9.8) | 2 (5.4) | 0.664 |
| Gastrointestinal involvement, N (%) | 30 (36.6) | 15 (40.5) | 0.836 |
| Breast involvement, N (%) | 5 (6.1) | 3 (8.1) | 0.992 |
| Kidney or adrenal gland involvement, N (%) | 6 (7.3) | 8 (21.6) | 0.053 |
| Genital involvement, N (%) | 9 (11.0) | 5 (13.5) | 0.928 |
| Axial bone involvement, N (%) | 26 (31.7) | 13 (35.1) | 0.875 |
| Skin or muscle involvement, N (%) | 16 (19.5) | 12 (32.4) | 0.192 |
Abbreviations: ASCT, autologous hematopoietic stem cell transplantation; GCB, germinal center B‐cell‐like; IPI, International Prognostic Index; N, number; PET, positron emission tomography; SUV, standardized uptake value.